CNKSR1 serves as a scaffold to activate an EGFR phosphatase via exclusive interaction with RhoB-GTP

Kanako Nishiyama1,2, Masashi Maekawa3,4, Tomoya Nakagita5

  • 1Department of Hepato-Biliary-Pancreatic Surgery and Breast Surgery, Ehime University Graduate School of Medicine, Toon, Japan.

Life Science Alliance
|June 30, 2021
PubMed

Insights

Degradation of RhoB by CUL3/KCTD10 is crucial for HER2-positive breast cancer cell growth by regulating EGFR and HER2 phosphorylation. This finding offers a potential therapeutic target for HER2-positive breast cancers.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • HER2-positive breast cancer proliferation is driven by epidermal growth factor receptor (EGFR) and human EGFR 2 (HER2) phosphorylation.
  • Targeting phosphatases for these receptors presents a potential therapeutic strategy.

Purpose of the Study:

  • To investigate the role of RhoB degradation by the CUL3/KCTD10 complex in regulating EGFR and HER2 phosphorylation.
  • To elucidate the mechanism by which RhoB influences phosphatase activity in HER2-positive breast cancer cells.

Main Methods:

  • Utilized human protein arrays synthesized via a wheat cell-free system to identify protein interactions.
  • Investigated the effects of CUL3 and KCTD10 depletion on RhoB and PTPRH localization and activity.
  • Examined the interaction between RhoB-GTP, CNKSR1, and PTPRH.

Main Results:

  • RhoB degradation by CUL3/KCTD10 is essential for EGFR and HER2 phosphorylation.
  • CNKSR1 interaction with PTPRH, leading to EGFR phosphatase inactivation, is enabled by RhoB degradation.
  • Depletion of CUL3 or KCTD10 causes RhoB-GTP accumulation, leading to PTPRH activation.

Conclusions:

  • A novel mechanism for PTPRH activation via RhoB-GTP binding to CNKSR1 is proposed.
  • The CUL3/KCTD10-RhoB pathway is critical for maintaining EGFR and HER2 phosphorylation in HER2-positive breast cancer.
  • This pathway represents a potential therapeutic target for HER2-positive breast cancers.

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.5K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
15.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.7K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
81.5K
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
6.1K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
14.6K